No. J0219 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code.

What NDCs are billed under J0219?

CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 1 NDC under J0219, for Nexviazyme. The table on this page shows each one with its billing units per package.

What is the Medicare payment limit for J0219?

$83.816 per 4 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

What is one billing unit of J0219?

One unit of J0219 is 4 mg, as stated in the code's descriptor. Units to report = dose given ÷ 4 mg.

J0219 J-Code: Nexviazyme (avalglucosidase alfa-ngpt)

In short

J0219 is the HCPCS Level II code for injection, avalglucosidase alfa-ngpt, 4 mg. CMS assigns NDCs for Nexviazyme to it. One billing unit is 4 mg. The Medicare Part B payment limit is $83.816 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file

HCPCS codeJ0219

Billing unit4 mg

Descriptor: Injection, avalglucosidase alfa-ngpt, 4 mg
Short descriptor: Inj aval alfa-nqpt 4mg
Code set: HCPCS Level II, maintained by CMS
Effective: Apr 1, 2022

The billing unit is read from the descriptor. Confirm it against the CMS file before billing.

Medicare Part B payment limit

CMS ASP file

Payment limit per unit$83.816

Per4 mg

Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Units = dose given ÷ 4 mg. For example, 400 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

Dose given (mg)

HCPCS units (1 unit = 4 mg)

Modifier

NDC (11-digit)

NDC unit qualifier

NDC quantity

Enter the dose given to build the claim line.

NDCs billed under J0219

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 1 NDC to J0219 for Nexviazyme. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J0219 in the CMS ASP crosswalk
Drug	NDC (11-digit)	Labeler	Package	Billing units per package
Nexviazyme	58468-0426-01	Genzyme Corporation	1	25

J0219: common questions

Is J0219 a CPT code?: No. J0219 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J0219?: CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 1 NDC under J0219, for Nexviazyme. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J0219?: $83.816 per 4 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
What is one billing unit of J0219?: One unit of J0219 is 4 mg, as stated in the code's descriptor. Units to report = dose given ÷ 4 mg. J-code billing units.

J0219 — Injection, avalglucosidase alfa-ngpt, 4 mg